📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery. (2021)

First Author: Hampel H

Attributed to: Molecular Genetic Studies of Schizophrenia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2020.108081

PubMed Identifier: 32407924

Publication URI: http://europepmc.org/abstract/MED/32407924

Type: Journal Article/Review

Volume: 185

Parent Publication: Neuropharmacology

ISSN: 0028-3908